Clinical Trials

The following are trials currently active:

For more information please contact Dr. Rogerio I. Neves M.D., Ph.D. (Contact details)

 

PI Name

Protocol No.

Title

Drabick, Joseph

PSHCI-09-030

A Phase II Trial of Dasatinib in KIT-Positive Patients with Unresectable Locally Advanced or Stage IV Mucosal, Acral and Vulvovaginal Melanomas (E2607)

Neves, Rogerio

PSHCI-08-059

Multicenter Selective Lymphadenectomy Trial II (MSLT-II): A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients with Molecular or Histopathological Evidence of Metastases in the Sentinel Node, coordinated by the John Wayne Cancer Institute

Neves, Rogerio

PSHCI-08-080

Histological Features of Sentinel Lymph Node Biopsy for Malignant Melanoma as a Predictive Indicator for Completion Lymphadenectomy

Drabick, Joseph

PSHCI-09-067

Phase II Trial of High Dose Interleukin-2 followed by intermittent low dose Temozolomide in patients with Metastatic Malignant Melanoma

Neves, Rogerio

PSHCI-11-003

Whole Brain Radiotherapy following Local Treatment of Intracranial Metastases of Melanoma - A Randomized Phase III Trial (ANZMTG)

Drabick, Joseph

PSHCI-11-072

A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a-2b for Resected High-risk Melanoma